Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukemia.
暂无分享,去创建一个
[1] R. Weinberg,et al. Physical interaction of the retinoblastoma protein with human D cyclins , 1993, Cell.
[2] David M. Livingston,et al. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins , 1993, Cell.
[3] A. Sahin,et al. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. , 1992, Journal of the National Cancer Institute.
[4] D. Johnston,et al. Prognostic value of proliferating cell nuclear antigen expression in chronic lymphoid leukemia. , 1992, Blood.
[5] G. Gahrton,et al. Retinoblastoma gene deletions in b‐cell chronic lymphocytic leukemia , 1992, Genes, chromosomes & cancer.
[6] M. Bar‐eli,et al. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia , 1991 .
[7] H. Saito,et al. Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia. , 1991, Blood.
[8] Y. Qian,et al. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle , 1991, Cell.
[9] M. Belvin,et al. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells. , 1991, Oncogene.
[10] Joseph R. Nevins,et al. The E2F transcription factor is a cellular target for the RB protein , 1991, Cell.
[11] M. Raffeld,et al. Oncogene rearrangements in chronic B-cell leukemia. , 1991, Blood.
[12] M. Raffeld,et al. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. , 1991, Blood.
[13] S. Orrenius,et al. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. , 1991, Journal of immunology.
[14] C. Cordon-Cardo,et al. Altered expression of the retinoblastoma gene product in human sarcomas. , 1990, The New England journal of medicine.
[15] M. Cole,et al. Increased retinoblastoma gene expression is associated with late stages of differentiation in many different cell types. , 1990, Oncogene.
[16] W. Lee,et al. Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[17] S. Knuutila,et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. , 1990, The New England journal of medicine.
[18] G. Stein,et al. Failure to phosphorylate the retinoblastoma gene product in senescent human fibroblasts. , 1990, Science.
[19] R. Weinberg,et al. Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[20] David M. Livingston,et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element , 1989, Cell.
[21] Phang-lang Chen,et al. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation , 1989, Cell.
[22] J. Varley,et al. Structural rearrangement of the retinoblastoma gene in human breast carcinoma. , 1988, Science.
[23] J. Minna,et al. Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. , 1988, Science.
[24] S. Perry,et al. Studies of leukocyte kinetics in chronic lymphocytic leukemia. , 1968, Blood.
[25] P. Nowell,et al. Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients. , 1991, Leukemia & lymphoma.
[26] M. Bar‐eli,et al. Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia. , 1991, Blood.
[27] M. Seabright,et al. Chromosome abnormalities involving band 13q14 in hematologic malignancies. , 1987, Cancer genetics and cytogenetics.